as on September 13, 2025 at 1:29 am IST
Day's Low
2.48%
Downside
52 Week's Low
52 Week's High
46.28%
Downside
1160.33%
Upside
Check Citius Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$20.4M
EPS (TTM)
-2.08
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-41.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
15051100.00%
Compare market cap, revenue, PE, and other key metrics of Citius Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $20.4M | -95.25% | NA | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Citius Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Citius Pharmaceuticals Inc investment value today
Current value as on today
₹14,447
Returns
Returns from Citius Pharmaceuticals Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Citius Pharmaceuticals Inc. Average target price of $6
Get share price movements and forecasts by analysts on Citius Pharmaceuticals Inc.
What analysts predicted
79.83%UPSIDE
Target Price
$6
Current Price
$1.21
Analyzed by
9 Analysts
Target
$6.00
Citius Pharmaceuticals Inc target price $6, a slight upside of 79.83% compared to current price of $1.21. According to 9 analysts rating.
Search interest for Citius Pharmaceuticals Inc Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 221.9%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 166.5%
Price Dip
In the last 1 year, CTXR stock has moved down by -90.8%
Organisation | Citius Pharmaceuticals Inc |
Headquarters | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Industry | Health Technology |
CEO | Mr. Leonard L. Mazur |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Myron Z. Holubiak | Co-Founder & Executive Vice Chairman |
Dr. Alan Lader Ph.D. | Senior VP and Head of Clinical Operations & Quality Assurance |
Mr. Dhananjay G. Wadekar | Senior Vice President of Business Strategy |
Mr. Nikolas Burlew | Executive Vice President of Quality Assurance |
Mr. Leonard L. Mazur | Co-Founder, CEO, Chairman & Secretary |
Mr. Jaime Bartushak | Chief Business Officer & CFO |
Mr. Gary F. Talarico | Executive Vice President of Operations |
Ms. Ilanit Allen | Vice President of Investor Relations & Corporate Communications |
Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
Mr. Kelly Creighton Ph.D. | Executive Vice President of Chemistry, Manufacturing & Controls |
Citius Pharmaceuticals Inc share price today is $1.21 as on at the close of the market. Citius Pharmaceuticals Inc share today touched a day high of $1.21 and a low of $1.18.
Citius Pharmaceuticals Inc share touched a 52 week high of $15.25 on and a 52 week low of $0.65 on . Citius Pharmaceuticals Inc stock price today i.e. is closed at $1.21,which is 92.07% down from its 52 week high and 86.15% up from its 52 week low.
Citius Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Citius Pharmaceuticals Inc (CTXR) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Citius Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Citius Pharmaceuticals Inc share’s latest price of $1.21 as on September 13, 2025 at 1:29 am IST, you will get 8.2645 shares of Citius Pharmaceuticals Inc. Learn more about
fractional shares .
Citius Pharmaceuticals Inc stock has given -95.25% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?